Johnson & Johnson (JNJ) Rises But Trails Market: What Investors Should KnowZacks Investment Research • 02/27/24
Why Is Johnson & Johnson (JNJ) Down 0.2% Since Last Earnings Report?Zacks Investment Research • 02/22/24
5 Safe Dividend Aristocrats To Buy Now – Huge Wall Street Sell-Off Could Be Coming24/7 Wall Street • 02/21/24
Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare ConferenceBusiness Wire • 02/14/24
AMBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc. - AMAMBusiness Wire • 02/10/24